Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DX25F6USJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $21,196
Award facts
- Contract value 100% obligated
- $21,196.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with a ceiling value of $21,196.36. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order must be completed by September 10, 2025. As a child contract under a larger vehicle, this delivery order is executed pursuant to AmerisourceBergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Department of Defense, supplying medications and medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. The Indefinite Delivery Contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to provide specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. HUMIRA, a biologic immunosuppressant used primarily for rheumatoid arthritis and other autoimmune conditions, represents a specialized pharmaceutical product within the broader scope of medications procured through the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6USJ?
SPE2DX25F6USJ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 9, 2025.
How much is contract SPE2DX25F6USJ worth?
The government has obligated $21,196 on SPE2DX25F6USJ.
Is contract SPE2DX25F6USJ an order under another contract?
Yes. SPE2DX25F6USJ is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6USJ competed?
The extent of competition for SPE2DX25F6USJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award